A recent computational analysis of the TCGA database revealed that, although more or less severe depending on the types of mutations and localization of the mutation within the gene, patients with mutated TP53 HNSCC were shown to have reduced overall survival (23). The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.